Neurocrine Biosciences, Inc. - Common Stock (NQ:NBIX)
131.38
+0.19
(+0.15%)
Streaming Delayed Price
Updated: 10:42 AM EDT, Apr 23, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 54,893 |
| Open | 131.18 |
| Bid (Size) | 131.20 (200) |
| Ask (Size) | 131.55 (200) |
| Prev. Close | 131.18 |
| Today's Range | 131.18 - 132.48 |
| 52wk Range | 100.83 - 160.18 |
| Shares Outstanding | 100,100,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why Soleno Therapeutics Stock Rocketed Higher on Monday ↗
April 06, 2026
Neurocrine (NBIX) Q4 2025 Earnings Call Transcript ↗
February 11, 2026
Frequently Asked Questions
Is Neurocrine Biosciences, Inc. - Common Stock publicly traded?
Yes, Neurocrine Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Neurocrine Biosciences, Inc. - Common Stock trade on?
Neurocrine Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Neurocrine Biosciences, Inc. - Common Stock?
The ticker symbol for Neurocrine Biosciences, Inc. - Common Stock is NBIX on the Nasdaq Stock Market
What is the current price of Neurocrine Biosciences, Inc. - Common Stock?
The current price of Neurocrine Biosciences, Inc. - Common Stock is 131.38
When was Neurocrine Biosciences, Inc. - Common Stock last traded?
The last trade of Neurocrine Biosciences, Inc. - Common Stock was at 04/23/26 10:42 AM ET
What is the market capitalization of Neurocrine Biosciences, Inc. - Common Stock?
The market capitalization of Neurocrine Biosciences, Inc. - Common Stock is 13.15B
How many shares of Neurocrine Biosciences, Inc. - Common Stock are outstanding?
Neurocrine Biosciences, Inc. - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.